InvestorsHub Logo
Followers 35
Posts 2152
Boards Moderated 0
Alias Born 03/02/2011

Re: dirtmover post# 71685

Tuesday, 12/06/2011 11:12:28 AM

Tuesday, December 06, 2011 11:12:28 AM

Post# of 346262
Not exactly, this is a phase II clinical trial which showed an improved "Overall response rate". This is not the same as overall survival. If a tumor shrinks but does not improve quality of life or improve overall survival, it won't be used.

Phase III trials change practice, usually not phase II unless the results are extraordinary. Results are encouraging, but, please don't think its a home run or that oncologists will prescribe it.

IMO, if this drug improves overall survival, I will buy more! That announcement would be a home run.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News